By Victor Omondi The Food and Drug Administration (FDA) said Monday, December, 20, 2021, that the world's first injectable drug to minimize the risk of contracting HIV has been approved. Apretude, or its generic name, 'cabotegravir extended-release injectable suspension,' is an injectable medicine that can be used instead of daily HIV prophylaxis pills like Truvada […]
